Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).

NCT00211471 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

OTHER

Sponsor class

Stopped poor enrollment

Conditions

Severe Diabetic Retinopathy
Central Retinal Vein Occlusion
Chronic Inflammation
Infectious Diseases

Interventions

DRUG: anecortave acetate

Sponsor

Manhattan Eye, Ear & Throat Hospital

Collaborators

[object Object]